August 10, 2010 source: Send2Press Newswire
DAVIS, Calif., Aug. 10 (SEND2PRESS NEWSWIRE) — California IVF: Davis Fertility Center, Inc. (californiaivf.com), working in conjunction with Gene Security Network (genesecurity.net) leads the field in bringing a new test to patients that combines the detection of single-gene genetic disorders with a 24 chromosome screening.
Using Gene Security Network’s Parental Support™ technology, at-risk couples undergoing in vitro fertilization can now test developing embryos for a larger number of hereditary diseases before implantation and pregnancy. This pre-implantation genetic screening/diagnosis (PGD/PGS) tests for single gene disorders like Sickle Cell and chromosomal abnormalities like Down Syndrome with a single cell from each embryo. This is the first commercial application of these combined screenings.
GSN’s proprietary Parental Support(TM) technology is the first to leverage data informatics to deliver highly accurate single cell testing for chromosome abnormalities and genetic diseases. The company is based in Redwood City, CA, and supported by multiple grants from the National Institutes of Health and leading venture investors like Claremont Creek Ventures and Sequoia Capital. GSN’s technology is at the forefront of pre-implantation genetic testing and the demand for their services has been increasing rapidly. For more information, please visit PGD Experts or www.genesecurity.net. [Read more ...]